Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Cutis ; 25(2): 201-3, 206-9, 1980 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-7357887

RESUMEN

The records of all patients treated at Mount Sinai Medical Center of Greater Miami with a modified Goeckerman regimen from 1972 to 1977 were analyzed. When a stringent definition of "clearing" was applied, it was found that approximately half of the patients were cleared of their psoriasis on this regimen and that the time the patients remained clear following treatment averaged 125 days. The mean number of treatments required for clearing was twenty-four which is in the same range as reported for PUVA therapy. For those patients that cleared, this average number of treatments was a more important variable than the time over which the treatments were administered.


Asunto(s)
Alquitrán/uso terapéutico , Furocumarinas/uso terapéutico , Fotoquimioterapia , Psoriasis/terapia , Terapia Ultravioleta , Anciano , Femenino , Humanos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
2.
Arch Dermatol ; 115(10): 1188-91, 1979 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-507860

RESUMEN

Several commonly used emollients were studied as to their effectiveness in absorbing and filtering erythema-causing ultraviolet radiation in the 280 to 315 nm range (UVB). Planter's Peanut Oil (Standard Brands) and Mazola Corn Oil (Best Foods Inc) had no effect; Alpha Keri Bath Oil (Westwood Pharmaceuticals), mineral oil, and Johnson's Baby Oil (Johnson & Johnson Co) had minimal effects. Vaseline Petroleum Jelly (Chesebrough-Ponds Inc), petrolatum, and hydrophilic ointment substantially reduced the erythema that was induced by exposure to low doses of UVB radiation. Therefore, these emollients may interfere with the therapeutic effects of the ultraviolet radiation component of the Goeckerman treatment when it is administered in low doses to patients with psoriasis.


Asunto(s)
Fármacos Dermatológicos/farmacología , Emolientes/farmacología , Eritema/prevención & control , Rayos Ultravioleta/efectos adversos , Edema/etiología , Eritema/etiología , Humanos , Psoriasis/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA